BeyondSpring BYSI
NASDAQ BYSI
$0.75 +0.03 (+3.47%)
As of: Aug 21, 2026 · 2:03 PM EDT

BeyondSpring (BYSI) EBT Margin Growth (3y) (2024)

BeyondSpring (BYSI) EBT Margin Growth (3y) (2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.60 Bn 130.75 Bn 2.84 Bn -484.00
2 Regeneron Pharmaceuticals 85.93 Bn 77.93 Bn 3.93 Bn 132.00
3 Argenx Se 65.06 Bn 59.88 Bn 1.37 Bn 6,685.00
4 Moderna 56.22 Bn 51.08 Bn 52.00 Mn -2,054.00
5 BeOne Medicines 42.03 Bn 36.93 Bn 1.53 Bn 8,006.00
6 Alnylam Pharmaceuticals 31.65 Bn 28.34 Bn 992.69 Mn 9,980.00
7 BioNTech SE 27.70 Bn 9.31 Bn 668.28 Mn -9,922.00
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 31,363.00
9 Royalty Pharma 27.31 Bn 26.48 Bn - -5,319.00
10 BeyondSpring 30.64 Mn 30.64 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 509,850.00